The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury

BACKGROUND: Furosemide is commonly prescribed in critically ill patients with acute kidney injury (AKI). Existing data from observational studies and small clinical trials have significant limitations and have reported conflicting findings. There remains controversy on whether furosemide can impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagshaw, Sean M, Gibney, RT Noel, McAlister, Finlay A, Bellomo, Rinaldo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874544/
https://www.ncbi.nlm.nih.gov/pubmed/20459801
http://dx.doi.org/10.1186/1745-6215-11-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874544/
https://www.ncbi.nlm.nih.gov/pubmed/20459801
http://dx.doi.org/10.1186/1745-6215-11-50

Ejemplares similares